Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hiroshi Tokunaga is active.

Publication


Featured researches published by Hiroshi Tokunaga.


Carcinogenesis | 2010

Involvement of macrophage inflammatory protein 1α (MIP1α) in promotion of rat lung and mammary carcinogenic activity of nanoscale titanium dioxide particles administered by intra-pulmonary spraying

Jiegou Xu; Mitsuru Futakuchi; Masaaki Iigo; Katsumi Fukamachi; David B. Alexander; Hideo Shimizu; Yuto Sakai; Seiko Tamano; Fumio Furukawa; Tadashi Uchino; Hiroshi Tokunaga; Tetsuji Nishimura; Akihiko Hirose; Jun Kanno; Hiroyuki Tsuda

Titanium dioxide (TiO(2)) is evaluated by World Health Organization/International Agency for Research on Cancer as a Group 2B carcinogen. The present study was conducted to detect carcinogenic activity of nanoscale TiO(2) administered by a novel intrapulmonary spraying (IPS)-initiation-promotion protocol in the rat lung. Female human c-Ha-ras proto-oncogene transgenic rat (Hras128) transgenic rats were treated first with N-nitrosobis(2-hydroxypropyl)amine (DHPN) in the drinking water and then with TiO(2) (rutile type, mean diameter 20 nm, without coating) by IPS. TiO(2) treatment significantly increased the multiplicity of DHPN-induced alveolar cell hyperplasias and adenomas in the lung, and the multiplicity of mammary adenocarcinomas, confirming the effectiveness of the IPS-initiation-promotion protocol. TiO(2) aggregates were localized exclusively in alveolar macrophages and had a mean diameter of 107.4 nm. To investigate the underlying mechanism of its carcinogenic effects, TiO(2) was administered to wild-type rats by IPS five times over 9 days. TiO(2) treatment significantly increased 8-hydroxydeoxy guanosine level, superoxide dismutase activity and macrophage inflammatory protein 1alpha (MIP1alpha) expression in the lung. MIP1alpha, detected in the cytoplasm of TiO(2)-laden alveolar macrophages in vivo and in the media of rat primary alveolar macrophages treated with TiO(2) in vitro, enhanced proliferation of human lung cancer cells. Furthermore, MIP1alpha, also detected in the sera and mammary adenocarcinomas of TiO(2)-treated Hras128 rats, enhanced proliferation of rat mammary carcinoma cells. These data indicate that secreted MIP1alpha from TiO(2)-laden alveolar macrophages can cause cell proliferation in the alveoli and mammary gland and suggest that TiO(2) tumor promotion is mediated by MIP1alpha acting locally in the alveoli and distantly in the mammary gland after transport via the circulation.


Water Research | 2005

Use of cholinesterase activity as an indicator for the effects of combinations of organophosphorus pesticides in water from environmental sources.

Maiko Tahara; Reiji Kubota; Hiroyuki Nakazawa; Hiroshi Tokunaga; Tetsuji Nishimura


Chemical & Pharmaceutical Bulletin | 1984

Determination of Glucocorticoids by Liquid Chromatography. III. Application to Ointments and a Cream Containing Cortisone Acetate, Dexamethasone Acetate, Fluorometholone, and Betamethasone Valerate

Hiroshi Tokunaga; Toshio Kimura; Jiro Kawamura


Chemical & Pharmaceutical Bulletin | 1984

Analysis of Insulins by High-Performance Liquid Chromatography. III. Determination of Insulins in Various Preparations

Miyako Ohta; Hiroshi Tokunaga; Toshio Kimura; Hiroshi Satoh; Jiro Kawamura


Chemical & Pharmaceutical Bulletin | 1983

Analysis of Insulins by High-Performance Liquid Chromatography. II. Separation of Various Species of Insulins

Miyako Ohta; Hiroshi Tokunaga; Toshio Kimura; Hiroshi Satoh; Jiro Kawamura


Chemical & Pharmaceutical Bulletin | 1983

Determination of Ergometrine Maleate and Methylergometrine Maleate in Pharmaceutical Preparations by High-Performance Liquid Chromatography

Hiroshi Tokunaga; Toshio Kimura; Jiro Kawamura


Yakugaku Zasshi-journal of The Pharmaceutical Society of Japan | 1979

[Gas chromatographic determination of glucocorticoids as trimethylsilyl ether derivatives (author's transl)].

Hiroshi Tokunaga; Toshio Kimura; Jiro Kawamura


Yakugaku Zasshi-journal of The Pharmaceutical Society of Japan | 2008

Hazard identification of nanomaterials

Hiroyuki Tsuda; Hiroshi Tokunaga; Akihiko Hirose; Jun Kanno


Yakugaku Zasshi-journal of The Pharmaceutical Society of Japan | 1984

Analysis of Insulin by High-Performance Liquid Chromatography. IV. Stability of Insulin in Hydrochloric Acid

Miyako Ohta; Hiroshi Tokunaga; Toshio Kimura; Tsutomu Yamaha


Chemical & Pharmaceutical Bulletin | 1987

Determination of corticoids using pyrrole. V: Studies on the colored products

Hiroshi Tokunaga; Masayuki Tanno; Toshio Kimura

Collaboration


Dive into the Hiroshi Tokunaga's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jun Kanno

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Jiegou Xu

Nagoya City University

View shared research outputs
Researchain Logo
Decentralizing Knowledge